The Institute for Bioengineering and Biosciences (iBB) is an interdisciplinary research institute at the interface of life sciences and engineering, advancing health-focused research from disease mechanisms and modelling to advanced therapeutic medicinal products (ATMPs) and regenerative medicine.
iBB combines advanced spectroscopic and bioanalytical characterisation, microbiology and genomics, stem cell research, and 3D bioprinting and biomanufacturing, supported by integrated bioprocess engineering, to enable the development and translation of next-generation therapeutic and regenerative solutions.
Since 2018, iBB has contributed to over 70 national and 35 international R&D&I projects, demonstrating sustained scientific excellence in health-related research. iBB integrates the Portuguese nodes of ELIXIR, EATRIS, and Euro-BioImaging, supporting data-driven, imaging-intensive, and translational health research.
Interested in building Horizon Europe and strategic health partnerships? Let’s talk.
Scalable human in-vitro platforms based on iPSC-derived organoids and advanced 3D microtissues.
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Author
Research Manager at Institute for Bioengineering and Biosciences
Reproducible 3D tissue fabrication and controlled microenvironments for robust, transferable human-relevant platforms.
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Author
Research Manager at Institute for Bioengineering and Biosciences
Expertise in scalable ATMP biomanufacturing, quality control and robustness to support translation, logistics and regulatory alignment.
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Author
Research Manager at Institute for Bioengineering and Biosciences